-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
RVL Pharmaceuticals plc quarterly/annual Current Federal Tax Expense (Benefit) history and growth rate for Q1 2023.
- RVL Pharmaceuticals plc Current Federal Tax Expense (Benefit) for the quarter ending March 31, 2023 was $4.1M.
- RVL Pharmaceuticals plc annual Current Federal Tax Expense (Benefit) for 2022 was -$86K, a 55.2% increase from 2021.
- RVL Pharmaceuticals plc annual Current Federal Tax Expense (Benefit) for 2021 was -$192K, a 105% decline from 2020.
- RVL Pharmaceuticals plc annual Current Federal Tax Expense (Benefit) for 2020 was $4.15M.
Current Federal Tax Expense (Benefit), Quarterly (USD)